Chief Financial Officer
Thu, Apr 4, 2024
Apr 4
1,069 shares @ $2.63
Decreased holdings by -18.30%
7th largest trade (out of 18)
Trade made by an officer
10b5-1 scheduled trade
Insider trade was 94% below market price
Price 43% below 200-day moving average
BTAIBioXcel Therapeutics, Inc.
HealthcareDrug Manufacturers - Specialty & Generic
1D0.00%
1W+5.34%
1M+12.20%
3M—
6M—
1Y—